A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...

Genetic medicines-focused Scribe Therapeutics is racing toward the clinic on the heels of a preclinical data drop for three ...

This is a basic concept of natural selection in that those traits that make survival easier will be more likely to be passed ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Q3 2025 Management View President & COO Joseph Hazelton highlighted a pivotal shift, stating Dyadic is now operating as a “commercially focused biotechnology company with a growing portfolio of ...

Only one in every six million people have the Rh null blood type. Now researchers are trying to grow it in the laboratory in ...

A U.S. biological research institute has developed a new genetic modification technique that promises a wide range of organism mutations while being safer than the ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...